Psychiatry and Neurology, Neurology · Greensburg, PA
NPI
1659799476
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
540 South St Ste 301
Greensburg, PA, 15601
Phone (724) 261-5610
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
6,533 services
Medicare patients, 2024
501
Average age 71
Drug cost, 2024
$2.6M
2,333 prescriptions
Company payments, 2025
$44K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary E Kovacik Eicher was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,195 times for 11 patients. In total Mary E Kovacik Eicher billed 6,533 services in 40 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,195 | 11 | $4.98 | $21K |
| 99214 Office E&M - Established | Office | 367 | 269 | $79.68 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 322 | 249 | $12.27 | $3,952 |
| 99215 Office E&M - Established | Office | 185 | 151 | $131.08 | $24K |
| 95886 Electrical Nerve Conductivity | Office | 105 | 52 | $69.81 | $7,330 |
| 99213 Office E&M - Established | Office | 70 | 64 | $61.65 | $4,316 |
| 95874 Musculoskeletal | Office | 40 | 17 | $53.96 | $2,158 |
| 64615 Musculoskeletal | Office | 37 | 17 | $112.85 | $4,175 |
| 64616 Musculoskeletal | Office | 34 | 14 | $142.29 | $4,838 |
| 95911 Electrical Nerve Conductivity | Office | 23 | 23 | $142.96 | $3,288 |
| 99205 Office E&M - New | Office | 20 | 20 | $153.28 | $3,066 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 20 | 13 | $24.57 | $491 |
| 95910 Electrical Nerve Conductivity | Office | 12 | 12 | $115.07 | $1,381 |
By year: 2022 $91K for 955 services; 2023 $95K for 2,070 services; 2024 $122K for 6,533 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary E Kovacik Eicher prescribed most often to Medicare patients was Botox (Onabotulinumtoxina), with 240 prescriptions and refills. In total Mary E Kovacik Eicher wrote 2,333 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Botox Onabotulinumtoxina | 240 | 648 | 77 | $383K |
| Gabapentin Generic | 148 | 266 | 55 | $3,533 |
| Donepezil Hcl Generic | 107 | 211 | 38 | $1,025 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 101 | 223 | 42 | $5,319 |
| Levetiracetam Generic | 99 | 195 | 29 | $3,092 |
| Memantine Hcl Generic | 78 | 128 | 25 | $1,585 |
| Lamotrigine Generic | 64 | 114 | 19 | $435 |
| Topiramate Generic | 63 | 121 | 18 | $675 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 63 | 63 | Under 11 | $414K |
| Pregabalin Generic | 52 | 86 | 18 | $1,768 |
| Baclofen Generic | 49 | 91 | 20 | $1,358 |
| Clonazepam Generic | 46 | 47 | 15 | $162 |
| Propranolol Hcl Generic | 44 | 88 | 16 | $623 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 40 | 88 | 17 | $1,287 |
| Zonisamide Generic | 36 | 65 | 11 | $591 |
Brand drugs: - claims; generic drugs: 1,778 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary E Kovacik Eicher $44K ($44K in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $43K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 66 | $43K |
| Eisai Inc. 4523.T | 16 | $324 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $113 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $112 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $96.31 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $82.52 |
| Pfizer Inc. PFE | 5 | $74.48 |
| Lilly USA, LLC LLY | 3 | $69.68 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $36.52 |
| UCB, Inc. UCB.BR | 1 | $21.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.